Vol 4, No 3 (June 2015): Translational Andrology and Urology (Urological Oncology)

Review Article

Bacille-Calmette-Guerin non-responders: how to manage
Friedrich-Carl von Rundstedt, Seth P. Lerner
Standard cystectomy fits all: truth or myth?
Beat Roth, George N. Thalmann
Upper urinary tract disease: what we know today and unmet needs
Romain Mathieu, Karim Bensalah, Ilaria Lucca, Aurélie Mbeutcha, Morgan Rouprêt, Shahrokh F. Shariat
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
Isuru S. Jayaratna, Neema Navai, Colin P. N. Dinney
Indications for biopsy and the current status of focal therapy for renal tumours
Ricardo R.N. Leão, Patrick O. Richard, Michael A.S. Jewett
Outlining the limits of partial nephrectomy
Sameer Chopra, Raj Satkunasivam, Chandan Kundavaram, Gangning Liang, Inderbir S. Gill
Cytoreductive surgery in the era of targeted molecular therapy
Arun Z. Thomas, Mehrad Adibi, Leonardo D. Borregales, Jose A. Karam, Christopher G. Wood
Sequence of treatment in locally advanced and metastatic renal cell carcinoma
Stefanie Fischer, Silke Gillessen, Christian Rothermundt
The current and future role of magnetic resonance imaging in prostate cancer detection and management
Jan Philipp Radtke, Dogu Teber, Markus Hohenfellner, Boris A. Hadaschik
Active surveillance and focal therapy for low-intermediate risk prostate cancer
Laurence Klotz
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
Federica Recine, Cora N. Sternberg
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Thenappan Chandrasekar, Joy C. Yang, Allen C. Gao, Christopher P. Evans
Advances in the treatment of testicular cancer
Yaron Ehrlich, David Margel, Marc Alan Lubin, Jack Baniel


The focused issue “Urological Oncology” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. George N. Thalmann served as the unpaid Guest Editor for the focused issue.